These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4629286)

  • 21. Case report 288: osteomalacia and secondary hyperparathyroidism (dialysis-induced), with aluminum deposition.
    Llewellyn CH; Resnik CS; Brower AC
    Skeletal Radiol; 1984; 12(3):223-6. PubMed ID: 6494942
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic bone disease in patients on maintenance hemodialysis.
    Ritz E; Malluche H; Bommer J; Mehls O; Krempien B
    Nephron; 1974; 12(5):393-404. PubMed ID: 4824048
    [No Abstract]   [Full Text] [Related]  

  • 23. Osteomalacia after parathyroidectomy in patients with uremia.
    Felsenfeld AJ; Harrelson JM; Gutman RA; Wells SA; Drezner MK
    Ann Intern Med; 1982 Jan; 96(1):34-9. PubMed ID: 7053699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.
    Brickman AS; Sherrard DJ; Jowsey J; Singer FR; Baylink DJ; Maloney N; Massry SG; Norman AW; Coburn JW
    Arch Intern Med; 1974 Nov; 134(5):883-8. PubMed ID: 4613310
    [No Abstract]   [Full Text] [Related]  

  • 25. [Monstrous tumourous changes of the facial bones in secondary hyperparathyroidism (author's transl)].
    Pfeifle J; Koch H; Grabensee B; Knieriem HI
    Dtsch Med Wochenschr; 1974 Mar; 99(9):389-91. PubMed ID: 4828634
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of strontium on bone metabolism in hemodialysis patients].
    Gerstenfeld S; Hinojosa L; Serrano Arias M; Menéndez Rodríguez P; Fernández Martín JL; Marchante JM; García Alonso JI; Sanz-Medel A; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():52-6. PubMed ID: 12778855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Physiopathological problems of osteopathy in long term hemodialysis].
    Ritz E; Andrassy K; Krempien B; Lenhard V
    Med Welt; 1973 Apr; 24(14):517-22. PubMed ID: 4634139
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pathophysiology and treatment of renal osteodystrophy].
    Ionova D
    Vutr Boles; 1985; 24(6):23-9. PubMed ID: 3913143
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium and phosphorus metabolism and bone disease in uremia.
    Kleeman CR; Massry SG; Coburn JW; Popovtzer MM
    Clin Orthop Relat Res; 1970; 68():210-37. PubMed ID: 4905786
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bone changes induced by hormones in renal osteopathy. Studies on the macro- and microstructure of bones].
    von Babo H; Heuck F
    Radiologe; 1974 May; 14(5):225-31. PubMed ID: 4603368
    [No Abstract]   [Full Text] [Related]  

  • 32. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteocytes in chronic uremia. Differential count of osteocytes in human femoral bone.
    Krempien B; Geiger G; Ritz E; Büttner S
    Virchows Arch A Pathol Pathol Anat; 1973; 360(1):1-9. PubMed ID: 4199228
    [No Abstract]   [Full Text] [Related]  

  • 34. [Value of bone biopsy in the diagnosis of calcipenic osteopathy].
    Lozano-Tonkin C
    Z Rheumaforsch; 1972; 31(9):358-66. PubMed ID: 4653072
    [No Abstract]   [Full Text] [Related]  

  • 35. The measurement of periosteocytic enlargement in primary and secondary hyperparathyroidism.
    Meunier P; Bernard J; Vignon G
    Isr J Med Sci; 1971 Mar; 7(3):482-5. PubMed ID: 5567523
    [No Abstract]   [Full Text] [Related]  

  • 36. Elevated bone aluminum content in dialysis patients without osteomalacia.
    McCarthy JT; Kurtz SB; McCall JT
    Mayo Clin Proc; 1985 May; 60(5):315-20. PubMed ID: 3990380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
    Isaac R; Nivez MP; Piamba G; Fillastre JP; Ardaillou R
    Clin Nephrol; 1975 Jan; 3(1):14-7. PubMed ID: 1126058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [significance of PTH (1-84) assay in the management of chronic renal failure and the current status and future of the treatment of renal osteopathy].
    Akizawa T; Akiba T; Inaba M; Shigematsu T; Martin KJ
    Clin Calcium; 2005 Nov; 15(11):136-159. PubMed ID: 16315400
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical treatment in primary and secondary hyperparathyroidism.
    Coburn JW; Brickman AS; Massry SG
    Semin Drug Treat; 1972; 2(1):117-35. PubMed ID: 4261783
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum bioactive parathyroid hormone in hemodialysis patients.
    McCarthy JT; Klee GG; Kao PC; Hodgson SF
    J Clin Endocrinol Metab; 1989 Feb; 68(2):340-5. PubMed ID: 2918050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.